900件以上の腫瘍科手術実績 – ビュレント・カラゴズ教授は、33年の経験の専門経験を持ち、肉腫やリンパ腫などの複雑な症例を専門としています。
ソラック医師は、基底細胞癌（Basalioma）を含むさまざまな癌の治療を専門とし、ハジェテペ大学癌研究所で高度な研修を修了しています。
Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.
Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.
Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.
メリムスキー教授は、ソウラスキー医療センターの軟部組織・骨腫瘍科を率い、基底細胞癌の複雑な症例を専門としています。
Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr 18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery. • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations
Personal Information
Sex: Male
Born : 1968
Professional Experience
Gayrettepe Florence Nigthingale Hospital
Medical Oncology Department
Besiktas/Istanbul/Turkey (ongoing)
Education:
He became Professor (22/April /2016)
Medical Oncology
Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)
Istanbul University Oncology Institue,
Department of Medical Oncology
Medical Oncology Fellowship (December 2001-December2004)
Istanbul University, Istanbul Medical Faculty
Hemodialysis Traning (May1996-January1997)
Istanbul University ,bCerrahpasa Medical Faculty
Internal Medicine Residency (November 1991-November 1996)
Istanbul University ,bCerrahpasa Medical Faculty
Ege University Medical Faculty (1985-1991)
Professional Experience
February 1999-November 2001
Metropolitan Florence Nigthingale Hospital
American Cancer Center, Gayrettepe/İstanbul
April1997- October 1998
Bayraktar Dialysis Center
Güngören/ Istanbul
Membership
Turkish Medical Oncology Association
ENET(European Neuroendocrine Tumour Society)
ESMO
ASCO
Personal information
Title: Professor Doctor
Branch: Radiation Oncology
Work History:
1 GATA Military Medical Faculty
2 Gayrettepe Florence Nightingale Hospital
3 T.R. Demiroğlu Bilim University \ Associate Professor
4 T.R Demiroğlu Bilim University \ Professor
Medical Specialties and Subspecialties:
1 Head and Neck Cancers
2 Radiation Oncology
Priority treatments:
1 Prostate cancer
2 Conformal treatments
Special advanced health technologies:
1 Truebeam Stx Technology
2 Halcyons
Education
1991 - Istanbul University Istanbul Faculty of Medicine
1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation
Oncology Specialization Training
Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).
He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.
Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).
Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
Experience
2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL
2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer
2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital
2020 - 2021 Yüzüncü Yıl University Faculty of Medicine
2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.
2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department
2018 - 2021 Yüzüncü Yıl University Faculty of Medicine
2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital
2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant
2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist
2012 - 2015 Suleiman the Magnificent Training and Research Hospital,
2008 - 2012 Haseki Training and Research Hospital
2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.
Education
2018
İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji
2018
İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji
2012
İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları
2012
İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları
2007
Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi
この医師は、35年以上の経験を持つリーディングプラスチックサージャンであり、がん後、火傷、皮膚腫瘍の手術、成人および子供のための手および顎顔面手術を専門としています。<\/p>
彼は、Anadolu Medical Center、Mevki Military Hospital、GATA Haydarpaşa Training Hospital、Brooke Army Medical Center、Çorlu Military Hospitalなどの著名な機関で働いてきました。<\/p>
彼はイスタンブール大学医学部から一般医学の学位を取得し、アンカラGATA医科大学でプラスチックおよび再建外科を専門とし、The University of Texas MD Anderson Cancer Centerからフェローシップを受けました。<\/p>
この医師は60以上の論文を発表し、100以上の会議に参加しており、いくつかの国際外科学会のメンバーです。<\/p>
Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).
He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.
He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.
バルセロナ大学（バラゲール、1958年）医学・外科の博士
医療-外科皮膚科の専門家であり、45年以上の経験を持つ
サンパウ大学病院の皮膚科の臨床責任者であり、バルセロナ自治大学のモーズユニットのディレクター t
テクノン医療センターの創設以来の教員の一員
皮膚がんの予防、診断＆治療 — オンコダーマトロジーのパイオニア
モーズ顕微鏡手術 — 1,400〜2,000件以上の施術で、従来の切除よりも高い治癒率
光動力学療法、皮膚がんスクリーニング、太陽保護、STIの管理
サンパウ大学病院の皮膚科サービスの責任者
UABでのモーズ手術トレーニングプログラムのディレクター
Institut de Dermatologia GarcésとDerma Associatsの創設者＆ディレクター
以下を含む複数の科学論文の著者:
広範囲の眉の欠損の修復 (2021)
上唇紅の欠損の再建 (2016) t
人気のある書籍 「Cuando calienta el sol」（「When the Sun Shines」）、健康な日焼けのルーチンに関するガイドの著者
国際皮膚外科協会（ISDS）、ヨーロッパモーズ顕微鏡手術協会（ESMS）、スペイン皮膚科学および性病学アカデミー（AEDV）の会員
認知されたトップ皮膚科医、TopDoctorsでの平均評価は4.9/5、AiroMedicalでは9.9/10 u
スペイン語、カタロニア語、英語に流暢
テクノン医療センター
Carrer de Vilana, 12, 08022 バルセロナ
相談時間：
月曜日～金曜日 9:00–15:00 & 15:00–20:00
🥇 世界クラスのモーズ手術のパイオニアであり、最高水準の治癒率
🎯 精密に基づいた個別化された治療と美容再建治療
👨⚕️ 広範な学術的および教育的なプロファイルで、最先端のケアを保証
🌐 優れた国際的な評判、多言語対応、患者に焦点を当てた姿勢
予約の準備はできましたか？
オンラインおよび対面での相談を提供し、Bookimedでスムーズな予約プロセスを提供します。彼のクリニックは、多言語での専用の患者ケアと進んだ皮膚がん治療を提供しています。
Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.
Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.
アフメット・ビリジ先生は、メディポル・メガ大学病院にて肉腫および肺癌の治療を専門とし、28年の経験以上の豊富な経験を持ちます。
Education and Expertise
Selcuk University Meram Faculty of Medicine - Medical Education
Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization
Experience
Malatya State Hospital Internal Diseases Clinic
Ankara Oncology Hospital Medical Oncology Clinic
Erzurum Regional Training and Research Hospital Medical Oncology Clinic
AREAS OF INTEREST
Lung cancer
esophageal cancer
Gastric cancer
breast cancer
Gastrointestinal surgery
https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr
エルケ・イェーガー教授は1,100件の治療実績を持ち、41年の経験年にわたりFocusによってドイツ最優秀腫瘍専門医の一人として評価されています。
Dr. Ozcan Yildiz is an oncologist and hematologist at Medipol Mega University Hospital in Istanbul. He specializes in treating complex neuroendocrine tumors and gynecological cancers. Dr. Yildiz has published numerous studies in prestigious journals like Medical Oncology and International Journal of Cardiology. He works at a JCI-accredited facility recognized for its bone marrow transplant expertise.
Dr. Christiane Thallinger is an Austrian dermatologist and venereologist. She focuses on skin cancer and oncologic dermatology. She began her medical career in 1999. She completed dermatology training at the Medical University of Vienna. She later served as a senior physician in its Department of Dermatology.
Her expertise includes diagnosis and treatment of melanoma, basal cell carcinoma, and squamous cell carcinoma. She performs dermatosurgery, cryotherapy, and photodynamic therapy. She also manages skin side effects caused by cancer treatment.
She is active in patient care and academic research. She is recognized for her patient-centered approach and for advancing dermatologic oncology in Austria.
フォックス・ヴィオラ博士は、BKZゾーリンゲン血液腫瘍科・緩和医療科の主任医師です。同クリニックは、認定された集学的腫瘍センターです。フォックス博士は、ドイツおよびヨーロッパにおける腫瘍性疾患の薬物療法の第一人者であり、15年以上の臨床経験を有しています。
同博士は、ドイツ腫瘍学・血液腫瘍学会（GDHO）、ドイツ医師会、およびアメリカがん研究学会に所属しています。また、分子生物学の研究にも従事しており、その研究成果はがん治療および分子診断の発展に貢献しています。
主な専門領域は、化学療法、免疫療法、分子標的療法、および放射線療法です。フォックス博士は、革新的な治療法と患者への細やかな配慮で知られています。その取り組みにより、高い治癒率を達成し、同僚からの高い評価を得ています。
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 33年の経験 | 肉腫及びリンパ腫症例 | 希少がんを専門とし、腫瘍免疫学の研究を主導。900件以上の腫瘍学的処置を実施。40本以上の論文を執筆。 | トルコ | から $215 | |
| #2 | 20年の経験 | 頭頸部癌 | 頭頸部癌を専門とし、MDアンダーソンがんセンターにて研鑽を積む。フェローシップはハジェテペ大学がん研究所にて修了。 | トルコ | から $100 | |
| #3 | 41年の経験 | 複雑な肉腫症例 | 希少疾患である軟部組織・骨腫瘍科を率い、ESMOでファカルティを務める。肉腫治療および腫瘍免疫学に関する論文を多数発表している。 | イスラエル | から $950 | |
| #4 | 28年の経験 | 複雑な肉腫症例 | 希少かつ難治性の肉腫治療を専門とし、トルコを代表する腫瘍専門医の一人として広く認められている。 | トルコ | から $115 | |
| #5 | 41年の経験 | 肉腫の治療 | ドイツの肉腫治療における第一線の腫瘍専門医として高く評価されている。ノルトヴェスト病院の腫瘍科を統括し、ゲーテ大学で次世代の専門医を育成している。 | ドイツ | から $480 |